11/14/2024
3:24 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Cullinan Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
1:23 PM | Cullinan Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/07/2024
4:30 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:06 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:18 AM | Cullinan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
10:18 AM | Cullinan Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/31/2024
11:48 AM | Cullinan Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G/A | |
|
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Cullinan Therapeutics (Subject)
| Form SC 13G | |
10/16/2024
6:17 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
6:13 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:30 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:27 PM | Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
5:00 PM | Cullinan Therapeutics (Issuer)
Thistle Mary (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/08/2024
6:20 AM | Cullinan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
6:15 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
4:30 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
3:19 PM | Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
6:30 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:00 PM | Cullinan Therapeutics (Issuer)
Ryan David P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:00 PM | Cullinan Therapeutics (Issuer)
Martin Anne-Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:00 PM | Cullinan Therapeutics (Issuer)
Rosenberg Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:00 PM | Cullinan Therapeutics (Issuer)
Webster Stephen W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:00 PM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
5:00 PM | Cullinan Therapeutics (Issuer)
Ebeling Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
12:30 PM | BlackRock Inc. (Filed by)
Cullinan Therapeutics (Subject)
| Form SC 13G/A | |
06/04/2024
11:15 PM | Cullinan Therapeutics (Filer)
| Form EFFECT | |
06/03/2024
7:12 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2024
4:07 PM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
4:40 PM | Cullinan Therapeutics (Issuer)
Meek David D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
4:30 PM | Cullinan Therapeutics (Issuer)
Meek David D. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/16/2024
6:30 AM | Cullinan Therapeutics (Filer)
| Form ARS | |
05/16/2024
5:42 AM | Cullinan Therapeutics (Filer)
| Form DEFA14A | |
05/16/2024
5:40 AM | Cullinan Therapeutics (Filer)
| Form DEF 14A | |
05/08/2024
6:30 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:32 PM | Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024
7:58 PM | Cullinan Therapeutics (Issuer)
Fenton Mary Kay (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2024
8:02 PM | Cullinan Therapeutics (Issuer)
Fenton Mary Kay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
6:05 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
4:50 PM | Cullinan Therapeutics (Subject)
Flynn James E (Filed by)
| Form SC 13G | |
04/16/2024
6:14 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
7:50 PM | Cullinan Therapeutics (Issuer)
Nguyen Nate (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Trump won. Buy this coin now. (Ad) Juan Villaverde called the top and bottom of every crypto bull market since 2012.
He believes Bitcoin will go to $150,000 — or more.
But there’s one coin he thinks could go even higher. This could be his favorite coin. |
03/14/2024
6:22 AM | Cullinan Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
6:27 AM | Cullinan Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/14/2024
6:14 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
4:00 PM | Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:00 PM | Cullinan Therapeutics (Issuer)
Trigilio Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:00 PM | Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:00 PM | AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:00 PM | Cullinan Therapeutics (Issuer)
Savill Corrine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:01 PM | Blue Owl Capital Holdings LP (Filed by)
Cullinan Therapeutics (Subject)
| Form SC 13G | |
02/06/2024
9:09 AM | Cullinan Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G | |
02/02/2024
8:35 PM | Cullinan Therapeutics (Issuer)
Savill Corrine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:43 PM | Cullinan Therapeutics (Subject)
Savill Corrine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
6:00 PM | Cullinan Therapeutics (Issuer)
Savill Corrine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Cullinan Therapeutics (Subject)
| Form SC 13G | |
01/29/2024
3:27 PM | Cullinan Therapeutics (Subject)
Savill Corrine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
3:18 PM | Cullinan Therapeutics (Subject)
Savill Corrine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
3:15 PM | Cullinan Therapeutics (Filer)
| Form 8-K/A | |
01/08/2024
8:12 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
5:30 PM | AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:30 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:30 PM | Cullinan Therapeutics (Issuer)
Trigilio Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:30 PM | Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:30 PM | Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
5:00 PM | Cullinan Therapeutics (Issuer)
Trigilio Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
5:00 PM | Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
5:00 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
5:00 PM | Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
7:00 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
7:00 PM | Cullinan Therapeutics (Issuer)
Trigilio Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free CGEM Stock Alerts